Related Experiment Video

Updated: Jul 17, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Contamination of immunoassay controls with hepatitis C virus

P Simmonds, F McOmish, P McCullough

    Lancet (London, England)
    |June 27, 1992
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
    07:05

    In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

    Published on: November 28, 2017

    Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
    11:36

    Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

    Published on: May 29, 2020

    Related Experiment Videos

    Last Updated: Jul 17, 2026

    The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
    09:03

    The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

    Published on: February 3, 2012

    In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
    07:05

    In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

    Published on: November 28, 2017

    Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
    11:36

    Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

    Published on: May 29, 2020

    Related Concept Videos

    Hepatitis01:25

    Hepatitis

    Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
    Viral Hepatitis I: Introduction01:28

    Viral Hepatitis I: Introduction

    Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

    Articles linked to this work by shared authors, journal, and citation graph.

    Coronavirus disease 2019 subphenotypes and differential treatment response to convalescent plasma in critically ill adults: secondary analyses of a randomized clinical trial.

    Intensive care medicine·2022

    Pervasive RNA Secondary Structure in the Genomes of SARS-CoV-2 and Other Coronaviruses.

    mBio·2020

    Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories.

    mSphere·2020

    Correction to: Recommendations for the nomenclature of enteroviruses and rhinoviruses.

    Archives of virology·2020

    Recommendations for the nomenclature of enteroviruses and rhinoviruses.

    Archives of virology·2020

    A European multicentre evaluation of detection and typing methods for human enteroviruses and parechoviruses using RNA transcripts.

    Journal of medical virology·2019

    Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

    Lancet (London, England)·2026

    Robotic-arm-assisted versus conventional total knee replacement (RACER-Knee): a pragmatic, multicentre, participant-masked and assessor-masked, superiority, randomised controlled trial.

    Lancet (London, England)·2026

    Risk of transmission of amyloid β pathology via transfused blood products.

    Lancet (London, England)·2026

    Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial.

    Lancet (London, England)·2026

    Finger-actuated microfluidic device for point-of-care circulating cell-free nucleic acid extraction.

    Lab on a chip·2026

    Extending Quality Control Procedures for Multiplexed Clinical Assays.

    Clinical chemistry·2026

    Characteristics of Severe and Typical Agranulocytosis Induced by Antithyroid Drugs.

    Clinical pharmacology and therapeutics·2026

    Severe Alcohol-Associated Lactic Acidosis Presenting With Extreme Hyperlactataemia: A Case Report.

    Cureus·2026

    STINGing the brain: S-nitrosylation drives neuroinflammation in Alzheimer's disease.

    Cell chemical biology·2026

    Sigma metric and Quality Goal Index assessment of hemoglobin A1c analytical performance in an ambulatory accredited laboratory.

    Laboratory medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us